Clinical Edge Journal Scan

Clinical Edge Journal Scan

Clinical Edge Journal Scan Commentary: Multiple Sclerosis March 2022

Author:

Mark Gudesblatt, MD

• Read More

Clinical Edge Journal Scan

Web-based mindfulness program improves depressive symptoms in MS

• Read More

Clinical Edge Journal Scan

Early decline in lymphocyte count best predicts DMF-associated lymphopenia in relapsing MS

• Read More

Clinical Edge Journal Scan

Primary progressive MS: No difference in efficacy between rituximab and ocrelizumab in real world

• Read More

Clinical Edge Journal Scan

sNfL and disease course in progressive MS without acute inflammation: Is there a link?

• Read More

Clinical Edge Journal Scan

High or increasing sNfl level predictive of impending relapses in active multiple sclerosis

• Read More

Clinical Edge Journal Scan

Multiple sclerosis: Excellent response to SARS-CoV-2 vaccine in patients with MS

• Read More

Clinical Edge Journal Scan

Differential impact of multiple sclerosis therapies on SARS-CoV-2 vaccine-induced immune response

• Read More

Clinical Edge Journal Scan

Multiple sclerosis: Evidence spanning 3 decades finds no influence of DMTs on neoplasm incidence

• Read More

Clinical Edge Journal Scan

Multiple sclerosis relapses are prevalent after natalizumab cessation during pregnancy

• Read More